The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
January 31st 2025
Although there were increases in prescriptions during the studies’ durations, the proportion of anxiety or pain medications on the same day of intrauterine device (IUD) insertion procedures were low.
January 31st 2025
Mylan Inc. today announced it has signed a multi-year strategic alliance agreement with Walt Disney Parks and Resorts to help increase awareness of anaphylaxis, a life-threatening allergic reaction. The agreement includes updated maps in Disney's domestic theme parks and on its cruise ships as well as updated signage in the parks that highlight locations with EpiPen® and EpiPen Jr® Auto-Injectors. Over time, the companies also will introduce a variety of educational resources designed to increase awareness of and preparedness for severe allergic reactions.
Read More
Airport security agents using a new conversation-based screening method caught mock airline passengers with deceptive cover stories more than 20 times as often as agents who used the traditional method of examining body language for suspicious signs, according to new research published by the American Psychological Association.
Read More
HeartCare Channel to Launch in Hospitals Across the U.S.
November 6th 2014The American Heart Association/American Stroke Association and The Wellness Network are expanding their collaborative efforts to provide heart disease and stroke patients with an exciting new cardiovascular disease-focused in-hospital TV channel and on-demand video portal to improve health through education.
Read More
Janssen Research & Development, LLC today announced a collaboration with the International Union Against Tuberculosis and Lung Disease to include SIRTURO® in the STREAM study. The STREAM study is an ongoing, multi-center international randomized controlled trial to evaluate a standardized treatment regimen of anti-tuberculosis drugs for patients with multidrug-resistant tuberculosis.
Read More
Obesity Drug Liraglutide Demonstrates Weight Loss
November 6th 2014According to data presented at ObesityWeek 2014, 9 of 10 obese participants in the phase 3 SCALE Obesity and Prediabetes study lost weight with Novo Nordisk's liraglutide treatment alongside diet and exercise, compared with 65% receiving placebo.
Read More